Green Chemistry and In silico Techniques for Synthesis of Novel
Pyranopyrazole and Pyrazolo-pyrano-pyrimidine Derivatives as
Promising Antifungal Agents

Kalyani   Dhirendra   Asgaonkar; Trupti   Sameer   Chitre; Shital   Manoj   Patil; Krishna   Sambhajirao   Shevate; Ashwini   Kishan   Sagar; Dipti   Dattatray   Ghate; Parth   Anil   Shah

Abstract

Background: Every year Invasive Fungal Infections (IFI) are globally affecting millions of people. Candida albicans and Aspergillus niger have been reported as the most infectious and mortality-inducing fungal strains among all pathogenic fungi.

Aims & Objectives: To tackle this problem in the current study Pyranopyrazoles and Pyrazolopyrano- pyrimidine derivatives were developed using molecular hybridization, green chemistry and one-pot multicomponent reaction.

Materials and Methods: In the present work, New Chemical entities (NCE’s) were developed on the basis of Structure activity relationship. All designed NCE’s were screened for ADMET studies using the QikProp module of Schrodinger software. NCE’s with zero violations were further docked on the crystal structure of 14α demethylase, cytochrome P450 and thymidine synthase (PDB ID: 5V5Z, 7SHI, 1BID). Selected molecules were synthesized using green chemistry techniques and evaluated for in vitro antifungal activity against Candida albicans and Aspergillus niger.

Results and Discussion: Designed NCE’s (B1-12 and C1-11) showed favorable results in ADMET studies. In the docking study six compounds from series-B and five molecules from series- C showed good dock score and binding interaction when compared with the standard drugs. Compounds B-3 and C-4 showed the highest zone of inhibition activity against Candida albicans, where as B-1 and C-3 had shown highest zone of inhibition activity against Aspergillus niger.

Conclusion: Bicyclic ring (series B) showed better activity as compare to fused tricyclic ring (series C).

[1]
Shafiei M, Peyton L, Hashemzadeh M, Foroumadi A. History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action. Bioorg Chem  2020; 104: 104240.
 [http://dx.doi.org/10.1016/j.bioorg.2020.104240] [PMID: 32906036]

[2]
Bongomin F, Gago S, Oladele R, Denning D. Global and multi-national prevalence of fungal diseases—estimate precision. J Fungi  2017; 3(4): 57.
 [http://dx.doi.org/10.3390/jof3040057] [PMID: 29371573]

[3]
Banerjee S, Denning D, Chakrabarti A. One Health aspects & priority roadmap for fungal diseases: A mini-review. Indian J Med Res  2021; 153(3): 311-9.
 [http://dx.doi.org/10.4103/ijmr.IJMR_768_21] [PMID: 33906993]

[4]
Rayens E, Norris KA. Prevalence and healthcare burden of fungal infections in the United States, 2018. Open Forum Infect Dis  2022; 9(1): ofab593.
 [http://dx.doi.org/10.1093/ofid/ofab593] [PMID: 35036461]

[5]
Hussain A, Verma CK. Computational drug repurposing resources and approaches for discovering novel antifungal drugs against candida albicans N-myristoyltransferase. J Pure Appl Microbiol  2021; 15(2): 556-79.
 [http://dx.doi.org/10.22207/JPAM.15.2.49]

[6]
Gohil PB, Ahir RH. Prevalence of fungal infections in patients attending tertiary care teaching hospital, middle gujarat, india. Int J Microbiol Res  2020; 5(3): 364-7.

[7]
Huang YQ, Tremblay JA, Chapdelaine H, Luong ML, Carrier FM. Pulmonary mucormycosis in a patient with acute liver failure: A case report and systematic review of the literature. J Crit Care  2020; 56: 89-93.
 [http://dx.doi.org/10.1016/j.jcrc.2019.12.012] [PMID: 31881411]

[8]
Novais AG, Capelo J, Costa M, et al. Pulmonary mucormycosis: A case report. IDCases  2020; 22: e00993.
 [http://dx.doi.org/10.1016/j.idcr.2020.e00993] [PMID: 33240790]

[9]
Choudhary NK, Jain AK, Soni R, Gahlot N. Mucormycosis: A deadly black fungus infection among COVID-19 patients in India. Clin Epidemiol Glob Health  2021; 12: 100900.
 [http://dx.doi.org/10.1016/j.cegh.2021.100900] [PMID: 34746515]

[10]
Krishna V, Morjaria J, Jalandari R, Omar F, Kaul S. Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection. IDCases  2021; 25: e01172.
 [http://dx.doi.org/10.1016/j.idcr.2021.e01172] [PMID: 34075329]

[11]
Pagano G, García A, Cancino-Abarca S, et al. COVID-19, rejection, and cutaneous mucormycosis in a long-term liver transplant recipient – the vicious cycle of immunosuppression and opportunistic infections. J Liver Transpl  2022; 7: 100113.
 [http://dx.doi.org/10.1016/j.liver.2022.100113]

[12]
Egger M, Bellmann R, Krause R, Boyer J, Jakšić D, Hoenigl M. Salvage treatment for invasive aspergillosis and mucormycosis: challenges, recommendations and future considerations. Infect Drug Resist  2023; 16: 2167-78.
 [http://dx.doi.org/10.2147/IDR.S372546] [PMID: 37077251]

[13]
Aswal G, Rawat R, Dwivedi D, Prabhakar N, Kumar KR. Diagnosis and management of mucormycosis in the dental clinic: A guide for oral health professionals in India. J Family Med Prim Care  2022; 11(8): 4293-8.
 [http://dx.doi.org/10.4103/jfmpc.jfmpc_1373_21] [PMID: 36353040]

[14]
Gintjee TJ, Donnelley MA, Thompson GR III. Aspiring antifungals: Review of current antifungal pipeline developments. J Fungi  2020; 6(1): 28.
 [http://dx.doi.org/10.3390/jof6010028] [PMID: 32106450]

[15]
Wall G, Lopez-Ribot JL. Current antimycotics, new prospects, and future approaches to antifungal therapy. Antibiotics  2020; 9(8): 445.
 [http://dx.doi.org/10.3390/antibiotics9080445] [PMID: 32722455]

[16]
Beattie SR, Krysan DJ. Antifungal drug screening: Thinking outside the box to identify novel antifungal scaffolds. Curr Opin Microbiol  2020; 57: 1-6.
 [http://dx.doi.org/10.1016/j.mib.2020.03.005] [PMID: 32339892]

[17]
Girois SB, Chapuis F, Decullier E, Revol BGP. Adverse effects of antifungal therapies in invasive fungal infections: review and meta-analysis. Eur J Clin Microbiol Infect Dis  2006; 25(2): 138-49.
 [http://dx.doi.org/10.1007/s10096-005-0080-0] [PMID: 16622909]

[18]
Kanafani ZA, Perfect JR. Antimicrobial resistance: Resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis  2008; 46(1): 120-8.
 [http://dx.doi.org/10.1086/524071] [PMID: 18171227]

[19]
Wiederhold N. Antifungal resistance: Current trends and future strategies to combat. Infect Drug Resist  2017; 10: 249-59.
 [http://dx.doi.org/10.2147/IDR.S124918] [PMID: 28919789]

[20]
Centre for Disease Control and Prevention. Antimicrobial-Resistant Fungi. 2019. Available from: https://www.cdc.gov/fungal/antifungal-resistance.html

[21]
Liu J, Balasubramanian M. 1,3-beta-Glucan synthase: A useful target for antifungal drugs. Curr Drug Targets Infect Disord  2001; 1(2): 159-69.
 [http://dx.doi.org/10.2174/1568005014606107] [PMID: 12455412]

[22]
Rauseo AM, Coler-Reilly A, Larson L, Spec A. Hope on the horizon: Novel fungal treatments in development. Open Forum Infect Dis  2020; 7(2): ofaa016.
 [http://dx.doi.org/10.1093/ofid/ofaa016] [PMID: 32099843]

[23]
Mohamed N, Khaireldin NY, Fahmy A, El-Sayed A. Facile synthesis of fused nitrogen containing heterocycles as anticancer agents. Pharma Chem  2010; 2: 400-17.

[24]
Zida A, Bamba S, Yacouba A, Ouedraogo-Traore R, Guiguemdé RT. Anti- Candida albicans natural products, sources of new antifungal drugs: A review. J Mycol Med  2017; 27(1): 1-19.
 [http://dx.doi.org/10.1016/j.mycmed.2016.10.002] [PMID: 27842800]

[25]
Desai NC, Khasiya AG, Jadeja DJ, et al. Synthesis, antifungal ergosterol inhibition, antibiofilm activities, and molecular docking on β-tubulin and sterol 14-alpha demethylase along with DFT-based quantum mechanical calculation of pyrazole containing fused pyridine−pyrimidine derivatives. ACS Omega  2023; 8(41): 37781-97.
 [http://dx.doi.org/10.1021/acsomega.3c01722] [PMID: 37867649]

[26]
Tripathi B, Mishra A, Rai P, et al. A green and clean pathway: One pot, multicomponent, and visible light assisted synthesis of pyrano[2,3-c]pyrazoles under catalyst-free and solvent-free conditions. New J Chem  2017; 41(19): 11148-54.
 [http://dx.doi.org/10.1039/C7NJ01688C]

[27]
Aziz H, Zahoor AF, Shahzadi I, Irfan A. Recent synthetic methodologies towards the synthesis of pyrazoles. Polycycl Aromat Compd  2021; 41(4): 698-720.
 [http://dx.doi.org/10.1080/10406638.2019.1614638]

[28]
Mesa-Arango AC, Scorzoni L, Zaragoza O. It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug. Front Microbiol  2012; 3: 286.
 [http://dx.doi.org/10.3389/fmicb.2012.00286] [PMID: 23024638]

[29]
Scorzoni L, de Paula e Silva ACA, Marcos CM, et al. Antifungal therapy: New advances in the understanding and treatment of mycosis. Front Microbiol  2017; 8: 36.
 [http://dx.doi.org/10.3389/fmicb.2017.00036] [PMID: 28167935]

[30]
Zhang J, Tan D-J, Wang T, Jing S-S, Kang Y, Zhang Z-T. Synthesis, crystal structure, characterization and antifungal activity of 3,4-diaryl-1H-Pyrazoles derivatives. J Mol Struct  2017; 1149: 235-42.
 [http://dx.doi.org/10.1016/j.molstruc.2017.07.106]

[31]
Rastija V, Vrandečić K, Ćosić J, et al. Antifungal activities of fluorinated pyrazole aldehydes on phytopathogenic fungi, and their effect on entomopathogenic nematodes, and soil-beneficial bacteria. Int J Mol Sci  2023; 24(11): 9335.
 [http://dx.doi.org/10.3390/ijms24119335] [PMID: 37298285]

[32]
Chi X, Zhang H, Wu H, et al. Discovery of novel tetrazoles featuring a pyrazole moiety as potent and highly selective antifungal agents. ACS Omega  2023; 8(19): 17103-15.
 [http://dx.doi.org/10.1021/acsomega.3c01421] [PMID: 37214706]

[33]
Zhao T, Sun Y, Meng Y, et al. Design, synthesis and antifungal activities of novel pyrazole analogues containing the aryl trifluoromethoxy group. Molecules  2023; 28(17): 6279.
 [http://dx.doi.org/10.3390/molecules28176279] [PMID: 37687108]

[34]
Ahmad M, Halim A, Mohammed A, Ali Y, Al-Messri Z. Synthesis, characterization and evaluation of some pyranopyrazoles and pyranopyrimidinesderivatives as antioxidants for lubricating oils. Iraqi JSci  2014; 55(1): 1-11.

[35]
Sagatova AA, Keniya MV, Wilson RK, Monk BC, Tyndall JDA. Structural insights into binding of the antifungal drug fluconazole to saccharomyces cerevisiae lanosterol 14α-demethylase. Antimicrob Agents Chemother  2015; 59(8): 4982-9.
 [http://dx.doi.org/10.1128/AAC.00925-15] [PMID: 26055382]

[36]
Kapoor JK, Prakash R, Kumar A, Saini D, Arora L. Selective synthesis of 3‐(α,α‐Dibromoacetyl)‐4‐hydroxy‐6‐methyl‐2 H ‐pyran‐2‐one as an excellent precursor for the Synthesis of 2‐substituted 4‐(4‐hydroxy‐6‐methyl‐2 H ‐2‐oxopyran‐3‐yl)thiazoles as antimicrobial and antifungal agents. J Heterocycl Chem  2018; 55(4): 899-906.
 [http://dx.doi.org/10.1002/jhet.3116]

[37]
Sayed GH, Azab ME, Anwer KE. Conventional and microwave‐assisted synthesis and biological activity study of novel heterocycles containing pyran moiety. J Heterocycl Chem  2019; 56(8): 2121-33.
 [http://dx.doi.org/10.1002/jhet.3606]

[38]
Ram VJ, Goel A, Shukla PK, Kapil A. Synthesis of thiophenes and thieno[3,2-c]pyran-4-ones as antileishmanial and antifungal agents. Bioorg Med Chem Lett  1997; 7(24): 3101-6.
 [http://dx.doi.org/10.1016/S0960-894X(97)10153-6]

[39]
Vala ND, Jardosh HH, Patel MP. PS-TBD triggered general protocol for the synthesis of 4 H -chromene, pyrano[4,3- b]pyran and pyrano[3,2- c]chromene derivatives of 1 H -pyrazole and their biological activities. Chin Chem Lett  2016; 27(1): 168-72.
 [http://dx.doi.org/10.1016/j.cclet.2015.09.020]

[40]
Khare SP, Deshmukh TR, Sangshetti JN, Khedkar VM, Shingate BB. Ultrasound assisted rapid synthesis, biological evaluation, and molecular docking study of new 1,2,3-triazolyl pyrano[2,3- c]pyrazoles as antifungal and antioxidant agent. Synth Commun  2019; 49(19): 2521-37.
 [http://dx.doi.org/10.1080/00397911.2019.1631849]

[41]
Zhao T, Xu LL, Zhang Y, et al. Three new α -pyrone derivatives from the plant endophytic fungus Penicillium ochrochloronthe and their antibacterial, antifungal, and cytotoxic activities. J Asian Nat Prod Res  2019; 21(9): 851-8.
 [http://dx.doi.org/10.1080/10286020.2018.1495197] [PMID: 30129376]

[42]
Maddila S, Gorle S, Seshadri N, Lavanya P, Jonnalagadda SB. Synthesis, antibacterial and antifungal activity of novel benzothiazole pyrimidine derivatives. Arab J Chem  2016; 9(5): 681-7.
 [http://dx.doi.org/10.1016/j.arabjc.2013.04.003]

[43]
Ishak C, Metwally N, Wahbi H. In-vitro antimicrobial and antifungal activity of pyrimidine and pyrazolo- [1, 5-a] pyrimidine. Int J Pharm Phytopharmacological Res  2013; 2(6): 407-11.

[44]
Wu W, Lan W, Wu C, Fei Q. Synthesis and antifungal activity of pyrimidine derivatives containing an amide moiety. Front Chem  2021; 9: 695628.
 [http://dx.doi.org/10.3389/fchem.2021.695628] [PMID: 34322475]

[45]
Bhagchand J. Prasanta kumarsantra synthesis and evaluation of antimicrobial activity of pyrimidine derivatives. Asian J Pharm Clin Res  2019; 12: 156-63.
 [http://dx.doi.org/10.22159/ajpcr.2019.v12i5.30919]

[46]
Sowdari J, Gudi Y, Donthamsetty SV, Venkatapuram P, Adivireddy P. Green approach for the synthesis of a new class of diamidomethane‐linked benzazolylpyrazoles and evaluation as antifungals. J Heterocycl Chem  2019; 56(8): 2080-9.
 [http://dx.doi.org/10.1002/jhet.3569]

[47]
Shah P. Preparation, characterization, antibacterial, antifungal and antioxidant activities of novel pyrazole-thiazole derivatives. Indian J Chem  2021; 60(9): 1223-9.

[48]
Becerra D, Abonia R, Castillo JC. Recent applications of the multicomponent synthesis for bioactive pyrazole derivatives. Molecules  2022; 27(15): 4723.
 [http://dx.doi.org/10.3390/molecules27154723] [PMID: 35897899]

[49]
Reddy GM, Garcia JR, Zyryanov GV, Sravya G, Reddy NB. Pyranopyrazoles as efficient antimicrobial agents: Green, one pot and multicomponent approach. Bioorg Chem  2019; 82: 324-31.
 [http://dx.doi.org/10.1016/j.bioorg.2018.09.035] [PMID: 30415166]

[50]
Makhanya TR, Gengan RM, Kasumbwe K. Synthesis of fused indolo‐pyrazoles and their antimicrobial and insecticidal activities against anopheles arabiensis mosquito. ChemistrySelect  2020; 5(9): 2756-62.
 [http://dx.doi.org/10.1002/slct.201904620]

[51]
El-Assaly SA, Ismail AEHA, Bary HA, Abouelenein MG. Synthesis, molecular docking studies, and antimicrobial evaluation of pyrano[2, 3-c]pyrazole derivatives. Curr Chem Lett  2021; 10(3): 309-28.
 [http://dx.doi.org/10.5267/j.ccl.2021.3.003]

[52]
Viveka S, Dinesha , Madhu LN, Nagaraja GK. Synthesis of new pyrazole derivatives via multicomponent reaction and evaluation of their antimicrobial and antioxidant activities. Monatsh Chem  2015; 146(9): 1547-55.
 [http://dx.doi.org/10.1007/s00706-015-1428-5]

[53]
Elshaier Y, Barakat A, Al-Qahtany B, Al-Majid A, Al-Agamy M. Synthesis of pyrazole-thiobarbituric acid derivatives: Antimicrobial activity and docking studies. Molecules  2016; 21(10): 1337.
 [http://dx.doi.org/10.3390/molecules21101337] [PMID: 27735850]

[54]
Barakat A, Al-Majid AM, Al-Qahtany BM, et al. Synthesis, antimicrobial activity, pharmacophore modeling and molecular docking studies of new pyrazole-dimedone hybrid architectures. Chem Cent J  2018; 12(1): 29.
 [http://dx.doi.org/10.1186/s13065-018-0399-0] [PMID: 29541952]

[55]
Sapariya NH, Vaghasiya BK, Thummar RP, et al. Synthesis, characterization, in silico molecular docking study and biological evaluation of a 5-(phenylthio) pyrazole based polyhydroquinoline core moiety. New J Chem  2017; 41(19): 10686-94.
 [http://dx.doi.org/10.1039/C7NJ01962A]

[56]
Kathirvelan D, Haribabu J, Reddy BSR, Balachandran C, Duraipandiyan V. Facile and diastereoselective synthesis of 3,2′-spiropyrrolidine-oxindoles derivatives, their molecular docking and antiproliferative activities. Bioorg Med Chem Lett  2015; 25(2): 389-99.
 [http://dx.doi.org/10.1016/j.bmcl.2014.10.099] [PMID: 25435149]

[57]
Tummalacharla S, Padmaja P, Reddy PN. An efficient one-pot synthesis of pyrazolyl-thiazolidinedione hybrid analogues and evaluation of their antimicrobial activity. Chem Data Coll  2020; 29: 100507.
 [http://dx.doi.org/10.1016/j.cdc.2020.100507]

[58]
Release S. 2023-1: QikProp. New York, NY: Schrödinger, LLC 2021.

[59]
QikProp 44 User Manual. LLC, New York: Schrödinger 2015.

[60]
Charles S, Paul S, Edgar M, Anthony K, Saidi N. The Hunt for antipox compounds against Monkeypox Virus Thymidylate Kinase and scaffolding protein leveraging Pharmacophore modeling, molecular docking, ADMET Studies, and molecular dynamics simulation studies. Research Square 2023.
 [http://dx.doi.org/10.21203/rs.3.rs-3306551/v1]

[61]
Al-Jumaili MHA, Siddique F, Abul Qais F, et al. Analysis and prediction pathways of natural products and their cytotoxicity against HeLa cell line protein using docking, molecular dynamics and ADMET. J Biomol Struct Dyn  2023; 41(3): 765-77.
 [http://dx.doi.org/10.1080/07391102.2021.2011785] [PMID: 34861809]

[62]
Vikrama C, Karthikeyan M, Lakshmanan L, et al. Computational study of piper betle l. Phytocompounds by in silico and admet analysis for prediction of potential xanthine oxidase inhibitory activity. Bio Rxiv 2023.
 [http://dx.doi.org/10.1101/2023.01.13.523909]

[63]
Release S. 2023-1: MacroModel. New York, NY: Schrödinger, LLC 2021.

[64]
Release S. 2023-1: LigPrep. New York, NY: Schrödinger, LLC 2021.

[65]
Keniya MV, Sabherwal M, Wilson RK, et al. Crystal structure of full-length lanosterol14α-demethylases of prominent fungal pathogens candida albicans and candida glabrata provide tools for antifungal discovery. Antimicrob Agents Chemother  2018; 62(11): e01134-18.
 [PMID: 30126961]

[66]
Amaya JA, Lamb DC, Kelly SL, Caffrey P, Murarka VC, Poulos TL. Structural analysis of P450 AmphL from Streptomyces nodosus provides insights into substrate selectivity of polyene macrolide antibiotic biosynthetic P450s. J Biol Chem  2022; 298(4): 101746.
 [http://dx.doi.org/10.1016/j.jbc.2022.101746] [PMID: 35189143]

[67]
Release S. 2023-2: Protein Preparation Wizard; Epik, Schrödinger, LLC, NY, 2023; Impact, Schrödinger, LLC,NY. NY: Prime, Schrödinger, LLC 2023.

[68]
Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W. Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des  2013; 27(3): 221-34.
 [http://dx.doi.org/10.1007/s10822-013-9644-8] [PMID: 23579614]

[69]
Release S. 2023-1: Glide. NY: Schrödinger, LLC 2021.

[70]
Friesner RA, Murphy RB, Repasky MP, et al. Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. J Med Chem  2006; 49(21): 6177-96.
 [http://dx.doi.org/10.1021/jm051256o] [PMID: 17034125]

[71]
Friesner RA, Banks JL, Murphy RB, et al. Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem  2004; 47(7): 1739-49.
 [http://dx.doi.org/10.1021/jm0306430] [PMID: 15027865]

[72]
Halgren TA, Murphy RB, Friesner RA, et al. Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem  2004; 47(7): 1750-9.
 [http://dx.doi.org/10.1021/jm030644s] [PMID: 15027866]

[73]
Mecadon H, Rohman MR, Kharbangar I, et al. l-Proline as an efficicent catalyst for the multicomponent synthesis of 6-amino-4-alkyl/aryl-3-methyl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitriles in water. Tetrahedron Lett  2011; 52(25): 3228-31.
 [http://dx.doi.org/10.1016/j.tetlet.2011.04.048]

[74]
Saleh NM, El-Gazzar MG, Aly HM, Othman RA. Novel anticancer fused pyrazole derivatives as egfr and vegfr-2 dual tk inhibitors. Front Chem  2020; 7: 917.
 [http://dx.doi.org/10.3389/fchem.2019.00917] [PMID: 32039146]

[75]
Rodríguez-Tudela JL, Barchiesi F, Bille J, et al. Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect  2003; 9(8): i-viii.
 [http://dx.doi.org/10.1046/j.1469-0691.2003.00789.x]

[76]
Ruangpan L, Tendencia EA. Laboratory manual of standardized methods for antimicrobial sensitivity tests for bacteria isolated from aquatic animals and environment. In: Tigbauan,. Iloilo, Philippines: Aquaculture Department, Southeast Asian Fisheries Development Center. 2004.

Cite As

Recent Advances in Anti-Infective Drug Discovery

Green Chemistry and In silico Techniques for Synthesis of Novel Pyranopyrazole and Pyrazolo-pyrano-pyrimidine Derivatives as Promising Antifungal Agents

Abstract